Prevention of Rabies With Four Doses of Rabies Vaccine

Clinical trial NCT05545371 · UNKNOWN

Trial details

NCT number: NCT05545371
Sponsor: Changchun Zhuoyi Biological Co., Ltd
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Rabies Human Antibody

Start date: 2022-06-18
Primary completion: 2024-11-30
Enrollment: 2100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.